Science Explorer Interactive view Map
Company · Makati City · Philippines

Boehringer Ingelheim (Philippines)

boehringer-ingelheim.comROR OpenAlex
Research works
37
▼ 11% vs 2013–17
Citations
411
11.2 per fractional work
Top-10% rate
18.7%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: Boehringer Ingelheim (Philippines) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.27× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 8.93× its world share, 0 worksImmunology and Micro…Neuroscience: 0.76× its world share, 0 worksNeuroscienceMedicine: 3.67× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 0.58× its world share, 0 worksEconomics, Econometr…Psychology: 1.95× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.9×. Every wedge is a field page.

Which keywords describe research at Boehringer Ingelheim (Philippines)?

By fractional works in all years, weighted toward what it does more of than the world: Diagnosis, Treatment, Epidemiology, Integrative Medicine, Traditional Chinese Medicine, Glycemic Control, Insulin Therapy and Heart Failure.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 32 words, with their numbers
  1. Epidemiology3▲ 2.0×15 topics
  2. Diagnosis2▲ 5.8×6 topics
  3. Treatment2▲ 4.7×6 topics
  4. Inflammation2▲ 2.5×11 topics
  5. Glycemic Control2▲ 29×3 topics
  6. Insulin Therapy2▲ 36×3 topics
  7. Integrative Medicine2▲ 55×2 topics
  8. Traditional Chinese Medicine2▲ 26×2 topics
  9. Heart Failure1▲ 8.1×4 topics
  10. Metabolic Regulation1▲ 12×3 topics
  11. Risk Factors1▲ 3.0×3 topics
  12. Antithrombotic Therapy1▲ 28×1 topic
  13. Cardiovascular Disease1▲ 2.6×9 topics
  14. Clinical Practice Guidelines1▲ 5.5×2 topics
  15. Complications1▲ 6.0×5 topics
  16. Mitochondrial Dysfunction1▲ 8.1×3 topics
  17. Precision Medicine1▲ 9.7×3 topics
  18. Prophylaxis1▲ 22×2 topics
  19. Venous Thromboembolism1▲ 44×1 topic
  20. Ayurveda1▲ 71×1 topic
  21. Brown Adipose Tissue1▲ 37×1 topic
  22. Diabetes1▲ 5.4×6 topics
  23. Global Burden1▲ 5.3×6 topics
  24. Human Metapneumovirus1▲ 60×1 topic
  25. Insulin Resistance1▲ 6.1×2 topics
  26. Legumes1▲ 63×1 topic
  27. Oxidative Stress1▲ 1.53×7 topics
  28. Remote Sensing1▲ 2.5×2 topics
  29. Respiratory Syncytial Virus1▲ 60×1 topic
  30. Symbiosis1▲ 22×1 topic
  31. Syndrome Differentiation1▲ 71×1 topic
  32. Thermogenesis1▲ 37×1 topic

Which research topics does Boehringer Ingelheim (Philippines) publish most on?

By volume in 2022–2025: Heart Failure Treatment and Management, Diabetes Treatment and Management, Psoriasis: Treatment and Pathogenesis and Dermatology and Skin Diseases.

Heart Failure Treatment and Management: 0 fractional worksDiabetes Treatment and Management: 0 fractional worksPsoriasis: Treatment and Pathogenesis: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksHyperglycemia and glycem…0Hyperglycemia and glycemic control in critically ill and hospitalized patients: 0 fractional worksMetabolism and Genetic Disorders: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional worksCardiovascular Function and Risk Factors: 0 fractional worksPancreatic function and diabetes: 0 fractional worksDialysis and Renal Disease Management: 0 fractional works
Cardiology and Cardiovascular MedicineEndocrinology, Diabetes and MetabolismImmunologyDermatology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
  2. 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  4. 4 Dermatology and Skin Diseases Dermatology 0 works
  5. 5 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
  6. 6 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
  7. 7 Drug Transport and Resistance Mechanisms Oncology 0 works
  8. 8 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
  9. 9 Pancreatic function and diabetes Surgery 0 works
  10. 10 Dialysis and Renal Disease Management Nephrology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.3%not open54.7%

World: 28% of research is openly available.

with international co-authors48.3%domestic only51.7%

World: 19% is written across borders.

How has Boehringer Ingelheim (Philippines)'s research output changed?

Output in 2018–2022 was 11% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Makati City

All research institutions in Makati City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.